Furthermore, serum IGFBP2 levels were correlated with tumor size in lung cancer [18], and the levels significantly dropped after curative resection in patients with colorectal cancer [17]; both observations implicate serum IGFBP2 as an indicator for tumor burden. This evidence concerns the gene IGFBP2 and lung cancer.